AAISG 2021 Annual Meeting

May 1, 2021 to May 2, 2021

Didactic lectures allow the speakers to provide evidence based medical recommendations, updates and expert opinion.

Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 9 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Target Audience

Practicing allergists, pulmonologists and allied healthcare professionals in the field of allergy, asthma and immunology.

Learning Objectives

At the conclusion of this activity, participants should be able to:

1. Upon completion of this activity, participants should be able to detect patients who could be appropriately challenged to food or send to colleague for food challenge, if appropriate.

2.Upon completion of this activity, participants should be able to identify patient who would be good candidates for OIT or send to colleagues for OIT.

3. Upon completion of this activity, participants should be able to optimally bill for OIT.

4. Upon completion of this activity, participants should be able to continue to utilize or initiate telemedicine practice under the public health emergency including billing

5. Upon completion of this activitiy, participants should be able to utilize biologics for chronic nasal polyps.

Additional information
Disclosure: 

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewers, and other individuals in a position to control or influence the content of an activity must disclose all relevant financial relationships with any commercial interest that have occurred within the past 12 months. All identified conflicts of interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure be provided to the learners prior to the start of the activity. Individuals with no relevant financial relationships must also inform the learners that no relevant financial relationships exist. Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials. Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI. 

Course summary
Available credit: 
  • 9.00 AMA PRA Category 1 Credit™
  • 9.00 Attendance
Course opens: 
05/01/2021
Course expires: 
12/31/2023
Event starts: 
05/01/2021 - 9:00am CDT
Event ends: 
05/02/2021 - 2:30pm CDT
Add to calendar: 
Rating: 
0

All identified conflicts of interests have been resolved:

•Merin Kalangara, MD – Consultant for GlaxoSmithKline
•Brian Vickery, MD –    Consultant and Board Member for Aimmune 
            Consultant for AllerGenis
            Consultant for Aravax
            Investigator for DBV Technologies
            Investigator for Genentech
            Consultant and Investigator for Regeneron


The following have no relevant financial relationships to disclose: 

Jennifer Shih, MD – AAISG Program Chair
Julie Ellerbee – AAISG Staff   
Dixie Griffin, MD 
Katherine Tison, MD
Kelsey Fields, MD
Niraj Patel, MD
Safia Nawaz, MD
Teresa Thompson, CPC
Marybeth Sexton, MD

 

Available Credit

  • 9.00 AMA PRA Category 1 Credit™
  • 9.00 Attendance
Please login or create an account to take this course.